Ambien Short and Long-Term Side Effects
According to the American Academy of Sleep Medicine, up to 30% of adults have trouble sleeping, and 10% have insomnia severe enough to impact their daily lives.[1] For these people, sedative or hypnotic drugs like Ambien (zolpidem tartrate) can help them fall asleep, stay asleep, and get more restful sleep.
Ambien is intended as a short-term solution for insomnia, however. Taking Ambien for longer periods than intended – or at higher doses – may lead to tolerance and dependence with long-term side effects.

Frequently Asked Questions
What Happens If You Take Ambien for Years?
Ambien is only intended for short-term use – typically under 10 days. Taking Ambien for longer periods increases the risks of adverse effects, long-term complications, and dependency.
Can Ambien Cause Depression?
Ambien has a risk of serious side effects that are less common, including depression. The FDA identified a link between Ambien and depression, even in people who had never experienced depression before, and suicidal thoughts or actions.[14]
Does Ambien Cause Memory Loss?
In controlled studies, adults taking Ambien didn’t experience next-day memory impairment. One study revealed a decrease in the next-morning recall, which was presented during the drug’s peak effects, retrograde amnesia.[15] The study also indicated that anterograde amnesia, which prevents new memories from forming, may occur at high doses (above 10mg).
Does Ambien Make You Groggy?
With regular use of Ambien, headache, grogginess, drowsiness, and other mild symptoms are common. While unpleasant, these side effects are generally not serious or life-threatening.
How Safe Is Ambien?
Ambien is generally safe and effective when used as prescribed, but there are risks of serious side effects that can lead to injury or death. Long-term Ambien use or Ambien abuse side effects are more dangerous, including depression, suicidal thoughts and actions, and complex sleep behaviors.
Insomnia. (n.d.-f). Retrieved from https://aasm.org/resources/factsheets/insomnia.pdf on 2023, July 9.
Highlights of prescribing information need to be evaluated for comorbid … (n.d.-f). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf on 2023, July 9.
Drug scheduling. DEA. (n.d.-a). Retrieved from https://www.dea.gov/drug-information/drug-scheduling on 2023, July 9.
Highlights of prescribing information need to be evaluated for comorbid … (n.d.-f). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf on 2023, July 9.
Licata, S. C., Mashhoon, Y., Maclean, R. R., & Lukas, S. E. (2011, April). Modest abuse-related subjective effects of zolpidem in drug-naive volunteers. Behavioural pharmacology. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077937/ on 2023, July 9.
Zolpidem Tartrate (Ambien, Ambien CR, Edluar Zolpimist) (n.d.-f). Retrieved from https://portal.ct.gov/-/media/DCP/drug_control/PMP/pdf/zolpidempdf.pdf on 2024, February 15.
Review of Various Trials using zolpidem at Higher Doses … (2007, May). Retrieved from https://www.pbm.va.gov/PBM/vacenterformedicationsafety/Appendix1Detailsofhighdosezolpidemtrials.pdf on 2024, February 15.
Highlights of prescribing information need to evaluate for comorbid … (n.d.-f). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf on 2023, July 9.
Is Ambien safe for long-term use? … (2023, May). Retrieved from https://www.drugs.com/medical-answers/ambien-safe-long-term-3573886/ on 2024, February 15.
Highlights of prescribing information need to evaluate for comorbid … (n.d.-f). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf on 2023, July 9.
Questions and Answers: Risk of next-morning impariment after use of insomnia drugs … (2018, February 13). Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/questions-and-answers-risk-next-morning-impairment-after-use-insomnia-drugs-fda-requires-lower on 2024, February 15.
Mattoo, S. K., Gaur, N., & Das, P. P. (2011). Zolpidem withdrawal delirium. Indian journal of pharmacology, 43(6), 729–730. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229797/ on 2024, February 15.
Mayo Foundation for Medical Education and Research. (2023, April 5). Insomnia treatment: Cognitive behavioral therapy instead of Sleeping Pills. Mayo Clinic. Retrieved from https://www.mayoclinic.org/diseases-conditions/insomnia/in-depth/insomnia-treatment/art-20046677 on 2023, July 9.
Kripke, D. F. (2016, May 19). Hypnotic drug risks of mortality, infection, depression, and cancer: But lack of benefit. F1000Research. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890308/ on 2023, July 9.
Highlights of prescribing information need to evaluate for comorbid … (n.d.-f). Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf on 2023, July 9.